Grant: Alliance Grants
McGill University
$25,000.00
Assessment of biomimetic transepithelial implant integration in organ-on-a-chip skin and gingiva equivalent models
EF 2023-24
Résumé
One in every nine hospital patients in Canada contracts an infection. Each year, these infections lead to at least 8,000 deaths. Infections arise when medical devices that penetrate through the skin, called transepithelial devices, fail to create a seal, thus breaking the body's protective barrier. Current treatments are based on antibiotics but, to prevent infections altogether, we can draw inspiration from how teeth penetrate the gum's skin barrier without causing infections. This happens because of the strong connection between gums and the surface of the teeth, which is composed of a mix of minerals and collagen called cementum. Inspired by this, Professor Cerruti's group at McGill University has created biomimetic cementum coatings on the surface of transepithelial medical devices. To test if the coatings work, usually researchers have to recur to animal tests. But animal physiology is not the same as human's and there's a rising demand for cruelty-free alternatives in medical device testing. In this project, we'll assess the coatings developed in Cerruti's group using an in vitro model that mimics skin and gum tissues developed by Prof. Sriram's team at National University of Singapore (NUS). Built using human derived cells and organ-on-chip technology, these in-vitro models are living, three-dimensional tissues that reproduce human physiology. If successful, results from this project will a. validate the lab-on-chip models as alternatives to animal tests to evaluate implant integration and b. propose new biomimetic coatings that will improve integration of current transepithelial implants, potentially reducing infections in patients in Canada and beyond. This project will also advance Canada's global collaborations and leadership in biomaterials research, bringing together two researchers with complementary expertise in material surfaces (Cerruti) and organ-on-a-chip models (Sriram). Both researchers have an excellent record of publications, scientific achievements, and commitment to EDI practices. Combining their expertise and the facilities in both universities will ensure success of this catalyst project, providing ground for tackling the problem of hospital-associated infections on a larger scale.
Programme
Alliance Grants
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
588506-2023
Name nom
Cerruti, Marta MG
Department département
Mining & Materials Engineering.
Organization id
61
Institution établissement
McGill University
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2023
Competition year année de concours
2023
Award amount
25000
Program id
ALLRP
Program name en
Alliance Grants
Program name fr
Subventions Alliance
Group en
RESEARCH PARTNERSHIPS
Group fr
PARTENARIATS DE RECHERCHE
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
1102
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Biomedical engineering
Area of application fr
Génie biomédical
Research subject code
9100
Research subject group en
Recherche biomédicale
Research subject group fr
Medical sciences
Research subject en
Biomedical
Research subject fr
Sciences médicales
Application title
Assessment of biomimetic transepithelial implant integration in organ-on-a-chip skin and gingiva equivalent models
Keyword
In-vitro testing of biomaterials; Organ-on-a-chip; Soft tissue-biomaterial interactions; Surface modifications; Transepithelial implants
Application summary
One in every nine hospital patients in Canada contracts an infection. Each year, these infections lead to at least 8,000 deaths. Infections arise when medical devices that penetrate through the skin, called transepithelial devices, fail to create a seal, thus breaking the body's protective barrier. Current treatments are based on antibiotics but, to prevent infections altogether, we can draw inspiration from how teeth penetrate the gum's skin barrier without causing infections. This happens because of the strong connection between gums and the surface of the teeth, which is composed of a mix of minerals and collagen called cementum. Inspired by this, Professor Cerruti's group at McGill University has created biomimetic cementum coatings on the surface of transepithelial medical devices. To test if the coatings work, usually researchers have to recur to animal tests. But animal physiology is not the same as human's and there's a rising demand for cruelty-free alternatives in medical device testing. In this project, we'll assess the coatings developed in Cerruti's group using an in vitro model that mimics skin and gum tissues developed by Prof. Sriram's team at National University of Singapore (NUS). Built using human derived cells and organ-on-chip technology, these in-vitro models are living, three-dimensional tissues that reproduce human physiology. If successful, results from this project will a. validate the lab-on-chip models as alternatives to animal tests to evaluate implant integration and b. propose new biomimetic coatings that will improve integration of current transepithelial implants, potentially reducing infections in patients in Canada and beyond. This project will also advance Canada's global collaborations and leadership in biomaterials research, bringing together two researchers with complementary expertise in material surfaces (Cerruti) and organ-on-a-chip models (Sriram). Both researchers have an excellent record of publications, scientific achievements, and commitment to EDI practices. Combining their expertise and the facilities in both universities will ensure success of this catalyst project, providing ground for tackling the problem of hospital-associated infections on a larger scale.